Approach to the Patient With Prolactinoma.
Auriemma RS, Pirchio R, Pivonello C, Garifalos F, Colao A, Pivonello R.
J Clin Endocrinol Metab. 2023 Aug 18;108(9):2400-2423. doi: 10.1210/clinem/dgad174.
Antigestogens.
Baird DT.
Br Med Bull. 1993 Jan;49(1):73-87. doi: 10.1093/oxfordjournals.bmb.a072607.
Norethynodrel.
[No authors listed]
IARC Monogr Eval Carcinog Risk Chem Hum. 1979 Dec;21:461-77.
Revised European Society of Endocrinology Clinical Practice Guideline for the management of aggressive pituitary tumours and pituitary carcinomas.
Raverot G, Burman P, Abreu AP, Heaney AP, van Hulsteijn L, Lin AL, Marcus H, McCormack A, Minniti G, Petersenn S, Popovic V, Theodoropoulou M, Trouillas J, Dekkers OM.
Eur J Endocrinol. 2025 May 30;192(6):R45-R78. doi: 10.1093/ejendo/lvaf100.
[Prolactinoma].
Glezer A, Bronstein MD.
Arq Bras Endocrinol Metabol. 2014 Mar;58(2):118-23. doi: 10.1590/0004-2730000002961.
Prolactinomas.
Katznelson L, Klibanski A.
Cancer Treat Res. 1997;89:41-55. doi: 10.1007/978-1-4615-6355-6_3.
Pituitary apoplexy: managing the life-threatening condition associated with pituitary adenomas.
Witek P.
Minerva Endocrinol. 2014 Dec;39(4):245-59. Epub 2014 Jul 29.
[Hormonal contraception].
Van Cauwenberge JR.
Rev Med Liege. 1992 May;47(5):221-36.
Pituitary tumor apoplexy associated with extrapontine myelinolysis during pregnancy: A case report.
Ye W, Huang W, Chen L, Yao C, Sheng S, Liu Z, Xue C, Xing W.
Medicine (Baltimore). 2021 Mar 12;100(10):e25075. doi: 10.1097/MD.0000000000025075.
Management of pituitary tumors in pregnancy.
Bronstein MD, Paraiba DB, Jallad RS.
Nat Rev Endocrinol. 2011 May;7(5):301-10. doi: 10.1038/nrendo.2011.38. Epub 2011 Mar 15.
